5 months AbbVie (ABBV) to Report Q1 Earnings: What’s in the Cards? Zacks
Investor focus is likely to be on the sales of AbbVie’s (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.
Investor focus is likely to be on the sales of AbbVie’s (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.